EMAIL THIS PAGE TO A FRIEND

Blood

Dynamin 2-dependent endocytosis is required for normal megakaryocyte development in mice.


PMID 25468568

Abstract

Dynamins are highly conserved large GTPases (enzymes that hydrolyze guanosine triphosphate) involved in endocytosis and vesicle transport, and mutations in the ubiquitous and housekeeping dynamin 2 (DNM2) have been associated with thrombocytopenia in humans. To determine the role of DNM2 in thrombopoiesis, we generated Dnm2(fl/fl) Pf4-Cre mice specifically lacking DNM2 in the megakaryocyte (MK) lineage. Dnm2(fl/fl) Pf4-Cre mice had severe macrothrombocytopenia with moderately accelerated platelet clearance. Dnm2-null bone marrow MKs had altered demarcation membrane system formation in vivo due to defective endocytic pathway, and fetal liver-derived Dnm2-null MKs formed proplatelets poorly in vitro, showing that DNM2-dependent endocytosis plays a major role in MK membrane formation and thrombopoiesis. Endocytosis of the thrombopoietin receptor Mpl was impaired in Dnm2-null platelets, causing constitutive phosphorylation of the tyrosine kinase JAK2 and elevated circulating thrombopoietin levels. MK-specific DNM2 deletion severely disrupted bone marrow homeostasis, as reflected by marked expansion of hematopoietic stem and progenitor cells, MK hyperplasia, myelofibrosis, and consequent extramedullary hematopoiesis and splenomegaly. Taken together, our data demonstrate that unrestrained MK growth and proliferation results in rapid myelofibrosis and establishes a previously unrecognized role for DNM2-dependent endocytosis in megakaryopoiesis, thrombopoiesis, and bone marrow homeostasis.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

T1378
Sigma 7-9®, ≥99% (titration), crystalline
C4H11NO3
154563
Tris(hydroxymethyl)aminomethane, ultrapure grade, ≥99.9%
C4H11NO3
252859
Tris(hydroxymethyl)aminomethane, ACS reagent, ≥99.8%
C4H11NO3
RDD008
Trizma® base, anhydrous, free-flowing, Redi-Dri, ≥99.9%
C4H11NO3
T6791
Trizma® base, BioXtra, pH 10.5-12.0 (1 M in H2O), ≥99.9% (titration)
C4H11NO3
T4661
Trizma® base, ≥99.9% (titration), crystalline
C4H11NO3
93352
Trizma® base, ≥99.0% (T)
C4H11NO3
93350
Trizma® base, puriss. p.a., ≥99.7% (T)
C4H11NO3
33742
Trizma® base, puriss. p.a., buffer substance, ≥99.5%
C4H11NO3
04577
Trizma® base, tested according to Ph Eur
C4H11NO3
93440
Trizma® base, certified reference material for titrimetry, certified by BAM, ≥99.5%
C4H11NO3
T2550000
Trometamol, European Pharmacopoeia (EP) Reference Standard
C4H11NO3
T6687
Tromethamine, meets USP testing specifications
C4H11NO3
RES3137T-A7
Tromethamine, PharmaGrade, Manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production., suitable for cell culture, meets USP testing specifications
C4H11NO3
RES3193T-A7
Tromethamine, PharmaGrade, Manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production, suitable for cell culture, Meets USP, EP, JPC, BP testing specifications.
C4H11NO3
PHR1347
Tromethamine, Pharmaceutical Secondary Standard; Certified Reference Material
C4H11NO3
1698002
Tromethamine, United States Pharmacopeia (USP) Reference Standard
C4H11NO3